Global Adeno-Associated Virus Vectors in Gene Therapy Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Format: PDF   |   Report ID: 5513402   |   Published Date: August 2022   |   Pages:  106  

Choose License
The Adeno-Associated Virus Vectors in Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Adeno-Associated Virus Vectors in Gene Therapy market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Alzheimer's Disease accounting for % of the Adeno-Associated Virus Vectors in Gene Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Serotype 2 (AVV 2) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Adeno-Associated Virus Vectors in Gene Therapy include Amicus Therapeutics, Asklepios Biopharmaceutical, BioMarin Pharmaceutical, Coave Therapeutics, and MeiraGTx, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Adeno-Associated Virus Vectors in Gene Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

    Serotype 2 (AVV 2)
    Synthetic Serotypes
    Others

Market segment by Application can be divided into

    Alzheimer's Disease
    Cystic Dibrosis
    Hemophilia B
    Parkinson's Disease

The key market players for global Adeno-Associated Virus Vectors in Gene Therapy market are listed below:

    Amicus Therapeutics
    Asklepios Biopharmaceutical
    BioMarin Pharmaceutical
    Coave Therapeutics
    MeiraGTx
    Neurocrine Biosciences
    Pfizer
    Roche Holding
    Sangamo Therapeutics
    Sarepta Therapeutics
    Spark Therapeutics
    Voyager Therapeutics
    NightstaRx

Market segment by region, regional analysis covers

    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Adeno-Associated Virus Vectors in Gene Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Adeno-Associated Virus Vectors in Gene Therapy, with price, sales, revenue and global market share of Adeno-Associated Virus Vectors in Gene Therapy from 2019 to 2022.
Chapter 3, the Adeno-Associated Virus Vectors in Gene Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adeno-Associated Virus Vectors in Gene Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Adeno-Associated Virus Vectors in Gene Therapy market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Adeno-Associated Virus Vectors in Gene Therapy.
Chapter 13, 14, and 15, to describe Adeno-Associated Virus Vectors in Gene Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Adeno-Associated Virus Vectors in Gene Therapy Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Serotype 2 (AVV 2)
        1.2.3 Synthetic Serotypes
        1.2.4 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Alzheimer's Disease
        1.3.3 Cystic Dibrosis
        1.3.4 Hemophilia B
        1.3.5 Parkinson's Disease
    1.4 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size & Forecast
        1.4.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume (2017-2028)
        1.4.3 Global Adeno-Associated Virus Vectors in Gene Therapy Price (2017-2028) 
    1.5 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity Analysis
        1.5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Total Production Capacity (2017-2028)
        1.5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
        1.6.2 Adeno-Associated Virus Vectors in Gene Therapy Market Restraints
        1.6.3 Adeno-Associated Virus Vectors in Gene Therapy Trends Analysis
2 Manufacturers Profiles
    2.1 Amicus Therapeutics
        2.1.1 Amicus Therapeutics Details
        2.1.2 Amicus Therapeutics Major Business
        2.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.1.4 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Asklepios Biopharmaceutical
        2.2.1 Asklepios Biopharmaceutical Details
        2.2.2 Asklepios Biopharmaceutical Major Business
        2.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.2.4 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 BioMarin Pharmaceutical
        2.3.1 BioMarin Pharmaceutical Details
        2.3.2 BioMarin Pharmaceutical Major Business
        2.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.3.4 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Coave Therapeutics
        2.4.1 Coave Therapeutics Details
        2.4.2 Coave Therapeutics Major Business
        2.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.4.4 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 MeiraGTx
        2.5.1 MeiraGTx Details
        2.5.2 MeiraGTx Major Business
        2.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.5.4 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Neurocrine Biosciences
        2.6.1 Neurocrine Biosciences Details
        2.6.2 Neurocrine Biosciences Major Business
        2.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.6.4 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.7.4 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Roche Holding
        2.8.1 Roche Holding Details
        2.8.2 Roche Holding Major Business
        2.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.8.4 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Sangamo Therapeutics
        2.9.1 Sangamo Therapeutics Details
        2.9.2 Sangamo Therapeutics Major Business
        2.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.9.4 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Sarepta Therapeutics
        2.10.1 Sarepta Therapeutics Details
        2.10.2 Sarepta Therapeutics Major Business
        2.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.10.4 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Spark Therapeutics
        2.11.1 Spark Therapeutics Details
        2.11.2 Spark Therapeutics Major Business
        2.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.11.4 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Voyager Therapeutics
        2.12.1 Voyager Therapeutics Details
        2.12.2 Voyager Therapeutics Major Business
        2.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.12.4 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 NightstaRx
        2.13.1 NightstaRx Details
        2.13.2 NightstaRx Major Business
        2.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
        2.13.4 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Adeno-Associated Virus Vectors in Gene Therapy Breakdown Data by Manufacturer
    3.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Adeno-Associated Virus Vectors in Gene Therapy
    3.4 Market Concentration Rate
        3.4.1 Top 3 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer Market Share in 2021
        3.4.2 Top 6 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer Market Share in 2021
    3.5 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Adeno-Associated Virus Vectors in Gene Therapy Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region
        4.1.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Region (2017-2028)
        4.1.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2017-2028)
    4.2 North America Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028)
    4.3 Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028)
    4.4 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028)
    4.5 South America Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028)
    4.6 Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Type (2017-2028)
    5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Type (2017-2028)
    5.3 Global Adeno-Associated Virus Vectors in Gene Therapy Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Application (2017-2028)
    6.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Application (2017-2028)
    6.3 Global Adeno-Associated Virus Vectors in Gene Therapy Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2028)
    7.2 North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2028)
    7.3 North America Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
        7.3.1 North America Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Country (2017-2028)
        7.3.2 North America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2028)
    8.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2028)
    8.3 Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
        8.3.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Country (2017-2028)
        8.3.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2028)
    9.2 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2028)
    9.3 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region
        9.3.1 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2028)
    10.2 South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2028)
    10.3 South America Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
        10.3.1 South America Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Country (2017-2028)
        10.3.2 South America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2028)
    11.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2028)
    11.3 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
        11.3.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Adeno-Associated Virus Vectors in Gene Therapy and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Adeno-Associated Virus Vectors in Gene Therapy
    12.3 Adeno-Associated Virus Vectors in Gene Therapy Production Process
    12.4 Adeno-Associated Virus Vectors in Gene Therapy Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors
    13.3 Adeno-Associated Virus Vectors in Gene Therapy Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

List of Tables Table 1. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028 Table 2. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028 Table 3. Amicus Therapeutics Basic Information, Manufacturing Base and Competitors Table 4. Amicus Therapeutics Major Business Table 5. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 6. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 7. Asklepios Biopharmaceutical Basic Information, Manufacturing Base and Competitors Table 8. Asklepios Biopharmaceutical Major Business Table 9. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 10. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 11. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors Table 12. BioMarin Pharmaceutical Major Business Table 13. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 14. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 15. Coave Therapeutics Basic Information, Manufacturing Base and Competitors Table 16. Coave Therapeutics Major Business Table 17. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 18. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 19. MeiraGTx Basic Information, Manufacturing Base and Competitors Table 20. MeiraGTx Major Business Table 21. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 22. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 23. Neurocrine Biosciences Basic Information, Manufacturing Base and Competitors Table 24. Neurocrine Biosciences Major Business Table 25. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 26. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 27. Pfizer Basic Information, Manufacturing Base and Competitors Table 28. Pfizer Major Business Table 29. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 30. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 31. Roche Holding Basic Information, Manufacturing Base and Competitors Table 32. Roche Holding Major Business Table 33. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 34. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 35. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors Table 36. Sangamo Therapeutics Major Business Table 37. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 38. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 39. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors Table 40. Sarepta Therapeutics Major Business Table 41. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 42. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 43. Spark Therapeutics Basic Information, Manufacturing Base and Competitors Table 44. Spark Therapeutics Major Business Table 45. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 46. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 47. Voyager Therapeutics Basic Information, Manufacturing Base and Competitors Table 48. Voyager Therapeutics Major Business Table 49. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 50. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 51. NightstaRx Basic Information, Manufacturing Base and Competitors Table 52. NightstaRx Major Business Table 53. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services Table 54. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 55. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg) Table 56. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million) Table 57. Market Position of Manufacturers in Adeno-Associated Virus Vectors in Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021 Table 58. Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity by Company, (Kg): 2020 VS 2021 Table 59. Head Office and Adeno-Associated Virus Vectors in Gene Therapy Production Site of Key Manufacturer Table 60. Adeno-Associated Virus Vectors in Gene Therapy New Entrant and Capacity Expansion Plans Table 61. Adeno-Associated Virus Vectors in Gene Therapy Mergers & Acquisitions in the Past Five Years Table 62. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2017-2022) & (Kg) Table 63. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2023-2028) & (Kg) Table 64. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2017-2022) & (USD Million) Table 65. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2023-2028) & (USD Million) Table 66. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2022) & (Kg) Table 67. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2023-2028) & (Kg) Table 68. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Type (2017-2022) & (USD Million) Table 69. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Type (2023-2028) & (USD Million) Table 70. Global Adeno-Associated Virus Vectors in Gene Therapy Price by Type (2017-2022) & (US$/Kg) Table 71. Global Adeno-Associated Virus Vectors in Gene Therapy Price by Type (2023-2028) & (US$/Kg) Table 72. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2022) & (Kg) Table 73. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2023-2028) & (Kg) Table 74. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Application (2017-2022) & (USD Million) Table 75. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Application (2023-2028) & (USD Million) Table 76. Global Adeno-Associated Virus Vectors in Gene Therapy Price by Application (2017-2022) & (US$/Kg) Table 77. Global Adeno-Associated Virus Vectors in Gene Therapy Price by Application (2023-2028) & (US$/Kg) Table 78. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2017-2022) & (Kg) Table 79. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2023-2028) & (Kg) Table 80. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2017-2022) & (USD Million) Table 81. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2023-2028) & (USD Million) Table 82. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2022) & (Kg) Table 83. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2023-2028) & (Kg) Table 84. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2022) & (Kg) Table 85. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2023-2028) & (Kg) Table 86. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2017-2022) & (Kg) Table 87. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2023-2028) & (Kg) Table 88. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2017-2022) & (USD Million) Table 89. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2023-2028) & (USD Million) Table 90. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2022) & (Kg) Table 91. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2023-2028) & (Kg) Table 92. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2022) & (Kg) Table 93. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2023-2028) & (Kg) Table 94. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2017-2022) & (Kg) Table 95. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2023-2028) & (Kg) Table 96. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2017-2022) & (USD Million) Table 97. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2023-2028) & (USD Million) Table 98. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2022) & (Kg) Table 99. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2023-2028) & (Kg) Table 100. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2022) & (Kg) Table 101. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2023-2028) & (Kg) Table 102. South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2017-2022) & (Kg) Table 103. South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2023-2028) & (Kg) Table 104. South America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2017-2022) & (USD Million) Table 105. South America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2023-2028) & (USD Million) Table 106. South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2022) & (Kg) Table 107. South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2023-2028) & (Kg) Table 108. South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2022) & (Kg) Table 109. South America Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2023-2028) & (Kg) Table 110. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2017-2022) & (Kg) Table 111. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2023-2028) & (Kg) Table 112. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2017-2022) & (USD Million) Table 113. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2023-2028) & (USD Million) Table 114. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2017-2022) & (Kg) Table 115. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2023-2028) & (Kg) Table 116. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2017-2022) & (Kg) Table 117. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2023-2028) & (Kg) Table 118. Adeno-Associated Virus Vectors in Gene Therapy Raw Material Table 119. Key Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy Raw Materials Table 120. Direct Channel Pros & Cons Table 121. Indirect Channel Pros & Cons Table 122. Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors Table 123. Adeno-Associated Virus Vectors in Gene Therapy Typical Customers List of Figures Figure 1. Adeno-Associated Virus Vectors in Gene Therapy Picture Figure 2. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Type in 2021 Figure 3. Serotype 2 (AVV 2) Figure 4. Synthetic Serotypes Figure 5. Others Figure 6. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Application in 2021 Figure 7. Alzheimer's Disease Figure 8. Cystic Dibrosis Figure 9. Hemophilia B Figure 10. Parkinson's Disease Figure 11. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028 Figure 12. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue and Forecast (2017-2028) & (USD Million) Figure 13. Global Adeno-Associated Virus Vectors in Gene Therapy Sales (2017-2028) & (Kg) Figure 14. Global Adeno-Associated Virus Vectors in Gene Therapy Price (2017-2028) & (US$/Kg) Figure 15. Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity (2017-2028) & (Kg) Figure 16. Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity by Geographic Region: 2022 VS 2028 Figure 17. Adeno-Associated Virus Vectors in Gene Therapy Market Drivers Figure 18. Adeno-Associated Virus Vectors in Gene Therapy Market Restraints Figure 19. Adeno-Associated Virus Vectors in Gene Therapy Market Trends Figure 20. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Manufacturer in 2021 Figure 21. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Manufacturer in 2021 Figure 22. Adeno-Associated Virus Vectors in Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021 Figure 23. Top 3 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer (Revenue) Market Share in 2021 Figure 24. Top 6 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer (Revenue) Market Share in 2021 Figure 25. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2017-2028) Figure 26. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Region (2017-2028) Figure 27. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028) & (USD Million) Figure 28. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028) & (USD Million) Figure 29. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028) & (USD Million) Figure 30. South America Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028) & (USD Million) Figure 31. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue (2017-2028) & (USD Million) Figure 32. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2017-2028) Figure 33. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Type (2017-2028) Figure 34. Global Adeno-Associated Virus Vectors in Gene Therapy Price by Type (2017-2028) & (US$/Kg) Figure 35. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2017-2028) Figure 36. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Application (2017-2028) Figure 37. Global Adeno-Associated Virus Vectors in Gene Therapy Price by Application (2017-2028) & (US$/Kg) Figure 38. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2017-2028) Figure 39. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2017-2028) Figure 40. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2017-2028) Figure 41. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2017-2028) Figure 42. United States Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 43. Canada Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 44. Mexico Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 45. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2017-2028) Figure 46. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2017-2028) Figure 47. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2017-2028) Figure 48. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2017-2028) Figure 49. Germany Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 50. France Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. United Kingdom Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Russia Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Italy Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 54. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2017-2028) Figure 55. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2017-2028) Figure 56. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2017-2028) Figure 57. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Region (2017-2028) Figure 58. China Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. Japan Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Korea Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. India Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 63. Australia Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 64. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2017-2028) Figure 65. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2017-2028) Figure 66. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2017-2028) Figure 67. South America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2017-2028) Figure 68. Brazil Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. Argentina Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 70. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2017-2028) Figure 71. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2017-2028) Figure 72. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2017-2028) Figure 73. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Region (2017-2028) Figure 74. Turkey Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Egypt Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 77. South Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million) Figure 78. Manufacturing Cost Structure Analysis of Adeno-Associated Virus Vectors in Gene Therapy in 2021 Figure 79. Manufacturing Process Analysis of Adeno-Associated Virus Vectors in Gene Therapy Figure 80. Adeno-Associated Virus Vectors in Gene Therapy Industrial Chain Figure 81. Sales Channel: Direct Channel vs Indirect Channel Figure 82. Methodology Figure 83. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us